US SEC Filings Daily Market Digest — February 22, 2026

23-02-2026

23-02-2026

Domino's Pizza Inc filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-062313), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits) as part of its financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard earnings-related 8-K with attached exhibits likely containing press release details.

23-02-2026

Atomera Inc filed a Form 8-K on February 23, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), indicating disclosure of unspecified other events with attached exhibits. No specific details on the events, transactions, financial metrics, or quantitative data are provided in the filing summary. This appears to be a multi-item, potentially voluntary informational filing with file size of 297 KB.

23-02-2026

MoonLake Immunotherapeutics filed a Form 8-K on February 23, 2026 (AccNo: 0001213900-26-018967), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating several material corporate developments, but specific transaction details, financial metrics, dollar values, and impacts are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or named entities beyond the filer are provided.

23-02-2026

CenterPoint Energy Inc. filed an 8-K on February 23, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided in the filing summary. Sector information is not specified.

23-02-2026

AppTech Payments Corp. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

23-02-2026

Barinthus Biotherapeutics plc filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary.

23-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 23, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, disclosures, or exhibits are provided, resulting in no quantifiable positive or negative metrics. This multi-item filing appears informational without disclosed financial or operational impacts.

23-02-2026

CENTENE CORP filed an 8-K on 2026-02-23 under Item 7.01 Regulation FD Disclosure, a voluntary filing to disclose material nonpublic information in compliance with Regulation FD. No specific financial metrics, transactions, guidance, or operational details are mentioned in the filing summary. Filing size is 154 KB with Accession Number 0001071739-26-000052.

23-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, with potential transfer of listing. Item 9.01 reports financial statements and exhibits. No quantitative financial metrics, transaction values, or further details on the delisting rationale or impacts are disclosed.

23-02-2026

Entravision Communications Corp filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-061961), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or any quantitative metrics are disclosed.

23-02-2026

K2 Capital Acquisition Corp filed an 8-K on 2026-02-23 under Item 8.01 Other Events announcing a Merger/Acquisition. No specific deal structure, parties involved, valuation, financial terms, or other quantitative details are disclosed in the provided filing metadata. Sector is not specified, and no positive or negative metrics are mentioned.

23-02-2026

Illinois Tool Works Inc filed a multi-item 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 1.02 termination of a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. The filing reflects both new commitments and the end of prior ones alongside additional financial obligations. No specific transaction details, values, or impacts are disclosed.

23-02-2026

The company filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers related to an officer change. Item 8.01 reports other events. No specific details on affected positions, names, reasons, or quantitative impacts are disclosed.

23-02-2026

Carlyle Secured Lending, Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

23-02-2026

Digi Power X Inc. filed an 8-K on February 23, 2026 (AccNo: 0001213900-26-018930, size 221 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure likely sharing material non-public information publicly, with exhibits attached, but specific content, financial metrics, or transaction details are NOT_DISCLOSED. No quantitative data, guidance changes, or directional impacts are evident from the filing metadata.

• ·AccNo: 0001213900-26-018930
• ·File size: 221 KB
• ·Sector: not specified

23-02-2026

Kinder Morgan, Inc. filed an 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure. No specific core event, financial metrics, transactions, guidance changes, or other quantitative details are disclosed in the provided filing information. This is a voluntary disclosure with no mentioned positive or negative performance indicators.

23-02-2026

Shorepower Technologies Inc. filed an 8-K on February 23, 2026, announcing completion of an acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), changes in control of the registrant (Item 5.01), departures/elections/appointments of directors and officers with compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). Item 9.01 includes financial statements and exhibits. No specific deal terms, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

Enertopia Corp. filed an 8-K on February 23, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific transactions, financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the filing summary. This appears to be an informational disclosure with attached exhibits, but content details are not provided.

23-02-2026

Miluna Acquisition Corp filed an 8-K on 2026-02-23 disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, terms, financial details, or transaction-related information are provided in the filing summary. No quantitative metrics, positive or negative changes, or merger/acquisition details are mentioned.

23-02-2026

Freshpet, Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details in the available summary. No positive or negative financial changes are detailed.

23-02-2026

Ovintiv Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific terms, values, financial impacts, or other metrics are disclosed in the available filing summary.

23-02-2026

Gilead Sciences, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction value, financial impacts, or other quantitative metrics are disclosed. This is a multi-item mandatory filing for Items 1.01 and 9.01 with Item 7.01 often accompanying forward-looking disclosures.

• ·AccNo: 0001104659-26-018314

23-02-2026

Easterly Government Properties, Inc. filed an 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This is an informational filing for financial results with no detailed performance indicators available.

23-02-2026

Zura Bio Ltd filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officers, reasons for change, or compensatory arrangements are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

23-02-2026

PENN Entertainment, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, personnel changes, disclosures, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

23-02-2026

ImmunityBio, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001326110-26-000025), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed results provided.

23-02-2026

Stepan Co filed an 8-K on February 23, 2026, reporting under Item 2.05 costs associated with exit or disposal activities, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing indicating material restructuring or disposal-related costs alongside voluntary material information disclosure. No specific dollar amounts, financial metrics, period-over-period changes, or other quantitative details are disclosed.

23-02-2026

Coronado Global Resources Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons, timing, or any quantitative metrics are provided. No positive or negative governance implications, board outcomes, or succession signals can be assessed due to lack of disclosed information.

23-02-2026

Foghorn Therapeutics Inc. filed an 8-K on 2026-02-23 disclosing officer or director changes, including departures, elections, appointments, or compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected positions, names, reasons for changes, timing, or any quantitative metrics such as compensation amounts or share counts are explicitly stated. This is an informational filing with all key leadership change details NOT_DISCLOSED.

23-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on February 23, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are provided in the filing summary. No financial metrics, transactions, or quantitative data are mentioned.

23-02-2026

Axsome Therapeutics, Inc. filed a Form 8-K on 2026-02-23 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics.

23-02-2026

ADC Therapeutics SA filed a Form 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific details on the agreement terms, transaction value, share counts, or financial impacts are provided in the filing summary. This represents a multi-item mandatory disclosure with no quantitative metrics or performance comparisons disclosed.

23-02-2026

Armata Pharmaceuticals, Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001104659-26-018333, size: 222 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided in the summary. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

23-02-2026

Veris Residential, Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing announcing financial results with exhibits attached.

23-02-2026

United Homes Group, Inc. filed a Form 8-K on 2026-02-23 reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No quantitative financial metrics, transaction values, positive or negative performance indicators, or period-over-period comparisons are disclosed. This is a multi-item informational filing with no specified directional impacts.

23-02-2026

ProCap Financial, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007682, Size: 277 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information to comply with Regulation FD, with exhibits attached. No quantitative financial metrics, transactions, guidance, or specific events are disclosed in the provided filing details.

• ·Filing date: 2026-02-23
• ·Accession Number: 0001493152-26-007682
• ·File size: 277 KB

23-02-2026

Dominion Energy, Inc. filed an 8-K on February 23, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

Resolute Holdings Management, Inc. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a new material definitive agreement, under Item 1.02 termination of a prior material definitive agreement, and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the nature of the agreements, transaction values, parties involved, or financial terms were provided. This multi-item filing signals significant contractual changes including both a new commitment and termination of an existing one, but lacks quantification of impacts.

23-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on February 23, 2026, reporting under Item 2.04 a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement, alongside Item 8.01 for other events and Item 9.01 for financial statements and exhibits. This multi-item filing indicates a potentially material credit or liquidity event, but no specific details, dollar values, or quantitative impacts are disclosed. No positive or offsetting metrics are mentioned.

23-02-2026

Real Asset Acquisition Corp. filed an 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01 related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, or impacts were disclosed in the provided filing summary. No quantitative data, comparisons, or scheduled events were mentioned.

23-02-2026

Gibraltar Industries, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts were disclosed in the provided filing information. This appears to be an informational disclosure with no quantitative data or directional implications mentioned.

23-02-2026

Genprex, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

23-02-2026

GameSquare Holdings, Inc. filed a Form 8-K on February 23, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or quantitative impacts provided. No positive or negative performance metrics are disclosed.

23-02-2026

Outdoor Holding Co filed an 8-K on February 23, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, events, positive or negative changes, or quantitative data are disclosed in the filing summary provided. This is a multi-item informational filing with no detailed content available for analysis.

23-02-2026

News Corp filed a Form 8-K on February 23, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the events or exhibits provided in the summary. No financial metrics, transactions, or impacts are mentioned.

23-02-2026

CULP INC filed an 8-K on 2026-02-23 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No financial metrics, transaction values, or period-over-period comparisons were disclosed.

23-02-2026

Borealis Foods Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001213900-26-019022), reporting solely under Item 8.01 Other Events. No specific details of the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

23-02-2026

Perpetua Resources Corp. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance indicators.

23-02-2026

Candel Therapeutics, Inc. filed an 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or events were provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or directional indicators disclosed.

23-02-2026

ALT5 Sigma Corp filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, any financial statements, exhibits, transactions, metrics, or impacts are disclosed. This appears to be an informational filing without quantified positive or negative developments.

23-02-2026

Strategy Inc filed a Form 8-K on February 23, 2026, reporting Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

23-02-2026

Peabody Energy Corp filed an 8-K on February 23, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

23-02-2026

Verisk Analytics, Inc. filed a Form 8-K on February 23, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or disclosures provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

23-02-2026

GeneDx Holdings Corp. filed an 8-K on February 23, 2026 (AccNo: 0001818331-26-000014), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

23-02-2026

Getty Images Holdings, Inc. filed an 8-K on February 23, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided. This appears to be an informational filing with no quantified financial metrics or directional impacts disclosed.

23-02-2026

ASP Isotopes Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001477932-26-000963), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. Critical information such as core events, numerical data, or impacts is NOT_DISCLOSED.

23-02-2026

Transcode Therapeutics, Inc. filed an 8-K on February 23, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative details are disclosed in the filing summary. This appears to be a voluntary disclosure with attached exhibits, but content details are NOT_DISCLOSED.

23-02-2026

Atara Biotherapeutics, Inc. filed a Form 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure filing with no specific transaction details, dollar values, share counts, financial metrics, or period-over-period comparisons provided. No positive or negative metrics are disclosed, preventing assessment of financial impacts or strategic outcomes.

23-02-2026

Service Properties Trust filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the filing summary provided. No positive, negative, or flat metrics are mentioned.

23-02-2026

Select Water Solutions, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001104659-26-018372, Size: 491 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material nonpublic information and other events, with exhibits attached. No specific core events, financial metrics, positive or negative changes, transactions, or quantitative data are disclosed in the provided filing information.

23-02-2026

Lakeland Industries Inc filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-062550), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, appointment/resignation status, reasons, or quantitative metrics are disclosed in the provided information.

23-02-2026

Fortress Biotech, Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 8.01 reports other events, and Item 9.01 lists financial statements and exhibits. No specific transaction values, financial impacts, or quantitative metrics are disclosed.

23-02-2026

BioNexus Gene Lab Corp filed an 8-K on February 23, 2026 (AccNo: 0001477932-26-000964, Size: 176 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. This is a multi-item informational filing with no quantified metrics or directional impacts provided.

23-02-2026

OFF THE HOOK YS INC. filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007690, Size: 259 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving a voluntary disclosure of information to comply with Regulation FD, with unspecified exhibits attached. No financial metrics, transactions, guidance, or other quantitative details are disclosed in the provided filing information.

23-02-2026

VisionWave Holdings, Inc. filed an 8-K on 2026-02-23 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, parties, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons were disclosed.

23-02-2026

OptimumBank Holdings, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events, which covers material events not specified elsewhere, and Item 9.01 Financial Statements and Exhibits, indicating attachments are included. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts provided.

• ·AccNo: 0001493152-26-007689
• ·File Size: 229 KB

23-02-2026

Gossamer Bio, Inc. filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No specific details on the core event, transaction, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a single-item voluntary disclosure with no mentioned positive or negative metrics.

23-02-2026

Avidity Biosciences, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001193125-26-062537, Size: 174 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits provided in the summary. No positive, negative, or flat performance metrics are disclosed.

23-02-2026

Pelican Acquisition Corp filed an 8-K on February 23, 2026 (AccNo: 0001829126-26-001553), disclosing information under Item 7.01 Regulation FD Disclosure and providing exhibits under Item 9.01 Financial Statements and Exhibits, related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, or timelines were explicitly stated in the provided filing summary. Sector details are not specified.

23-02-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on February 23, 2026 (AccNo: 0001493152-26-007694, Size: 756 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary Regulation FD compliance and attachment of exhibits. No specific core event, financial metrics, transactions, or other details are disclosed in the provided filing information.

23-02-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on February 23, 2026, under Item 8.01 reporting Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information.

23-02-2026

BrightSpire Capital, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

23-02-2026

Fulton Financial Corp filed a Form 8-K on 2026-02-23 under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing information. This is a multi-item informational filing with no quantified positive or negative impacts reported.

23-02-2026

Blue Foundry Bancorp filed an 8-K on February 23, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

23-02-2026

Allurion Technologies, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information to comply with Regulation FD, with exhibits attached. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing information.

23-02-2026

Fannie Mae filed an 8-K on February 23, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. No positive or negative performance indicators are mentioned.

23-02-2026

SOUTH PLAINS FINANCIAL, INC. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses unspecified other events considered material by the company along with attached exhibits, but no specific details, financial metrics, or quantitative data are provided in the summary. No positive or negative performance indicators are mentioned.

23-02-2026

Cadence Design Systems Inc filed an 8-K on February 23, 2026 (AccNo: 0000813672-26-000019), disclosing under Item 3.02 unregistered sales of equity securities. No quantitative details such as transaction value, share count, proceeds, recipients, or dates of sales were provided. This is a single-item mandatory filing with no financial metrics, positive or negative, disclosed.

23-02-2026

Inhibrx Biosciences, Inc. filed an 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure, providing voluntary disclosure of material non-public information, and Item 9.01 Financial Statements and Exhibits, attaching relevant materials. No specific transactions, financial metrics, period-over-period comparisons, or quantitative data are disclosed in the filing summary. No positive or negative performance metrics reported.

23-02-2026

Sturm Ruger & Co Inc filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

23-02-2026

Steel Dynamics Inc filed an 8-K on February 23, 2026 (AccNo: 0001104659-26-018398, Size: 212 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material impacts are mentioned.

23-02-2026

Dream Finders Homes, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001628280-26-010399), reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

Raymond James Financial Inc filed an 8-K on February 23, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, transaction details, or quantitative data are provided in the filing summary. This is a multi-item informational filing with no directional financial impact disclosed.

23-02-2026

Cannabist Co Holdings Inc. filed a Form 8-K on 2026-02-23 under Item 1.01 disclosing entry into a material definitive agreement. No details on the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are provided in the available information. No quantitative metrics, comparisons, or scheduled events are mentioned.

• ·Accession Number: 0001776738-26-000006
• ·File Size: 131 KB
• ·Single-item filing (Item 1.01 only)

23-02-2026

Trilogy Metals Inc. filed an 8-K on February 23, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure with attached exhibits.

23-02-2026

Socket Mobile, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0000944075-26-000008, Size: 294 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure of financial results. No specific revenue, earnings, guidance, balance sheet effects, or other quantitative financial metrics are disclosed in the provided filing information.

23-02-2026

Lincoln Educational Services Corp filed an 8-K on February 23, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure with no directional performance indicators available.

23-02-2026

WAFD INC filed an 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, which lists attached materials (details NOT_DISCLOSED). No financial metrics, transactions, period-over-period comparisons, or specific events detailed in the filing summary. This is an informational filing with no quantified positive or negative impacts disclosed.

23-02-2026

TRANSUITE.ORG INC. filed a Form 8-K on 2026-02-23 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No details on the agreement terms, counterparties, value, or financial impacts are disclosed.

23-02-2026

1ST SOURCE CORP filed a Form 8-K on February 23, 2026 (AccNo: 0000034782-26-000014, Size: 145 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events and any attached financial statements or exhibits are NOT_DISCLOSED. This is a multi-item voluntary disclosure with no quantitative metrics, transaction details, or directional financial impacts provided.

23-02-2026

BT Brands, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001477932-26-000975, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events or the financial statements and exhibits are NOT_DISCLOSED. No quantitative metrics, transactions, or scheduled events are mentioned.

23-02-2026

Ultra Clean Holdings, Inc. filed a Form 8-K on February 23, 2026, specifically under Item 9.01 for Financial Statements and Exhibits. No details on the content of the exhibits, any transactions, financial metrics, or material events were disclosed in the filing summary provided. This appears to be an informational filing with no quantified positive or negative impacts mentioned.

23-02-2026

ACV Auctions Inc. filed an 8-K on 2026-02-23 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing information. This is a standard multi-item earnings-related disclosure with no directional financial data available.

23-02-2026

Keysight Technologies, Inc. filed an 8-K on 2026-02-23 disclosing under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related filing, but no specific revenue, earnings, margins, guidance, or period-over-period metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.

23-02-2026

BioMarin Pharmaceutical Inc filed an 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

Summit Therapeutics Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed financial data available.

23-02-2026

Tarsus Pharmaceuticals, Inc. filed an 8-K on February 23, 2026, under Items 2.02 and 9.01, disclosing results of operations and financial condition along with financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are provided in the filing summary. This appears to be a standard earnings-related disclosure with no quantified metrics available.

23-02-2026

Myriad Genetics Inc filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the filing summary. Critical financial data including period-over-period comparisons, balance sheet effects, and outlook revisions are NOT_DISCLOSED.

23-02-2026

Backblaze, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001628280-26-010594), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure with attached exhibits.

23-02-2026

Hims & Hers Health, Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001773751-26-000019, Size: 8 MB) reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item earnings-related disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

• ·AccNo: 0001773751-26-000019
• ·File size: 8 MB
• ·Sector: not specified

23-02-2026

V2X, Inc. filed a Form 8-K on 2026-02-23 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing description. No period-over-period comparisons, positive or negative changes, or balance sheet details are available.

23-02-2026

Spring Valley Acquisition Corp. II filed an 8-K on 2026-02-23 under Item 5.07 disclosing submission of matters to a vote of security holders. No specific details on the matters submitted, vote outcomes, participating parties, or any quantitative metrics are explicitly stated in the filing summary provided. No positive or negative performance metrics, financial data, or transaction terms are mentioned.

23-02-2026

Avenue Therapeutics, Inc. filed an 8-K on 2026-02-23 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

23-02-2026

PDS Biotechnology Corp filed a Form 8-K on February 23, 2026 (AccNo: 0001140361-26-006410), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are disclosed. No financial metrics, transactions, or directional impacts are mentioned.

23-02-2026

Diamondback Energy, Inc. filed a Form 8-K on 2026-02-23 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided information. This is a standard earnings-related filing with no extracted quantitative data.

23-02-2026

NEXTNRG, INC. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

23-02-2026

NI Holdings, Inc. filed a Form 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for the change, timing details, or financial terms are disclosed in the provided filing summary. This is a standard governance disclosure without additional quantitative or qualitative details.

23-02-2026

MANGOCEUTICALS, INC. filed an 8-K on February 23, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing metadata. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

23-02-2026

EverQuote, Inc. filed an 8-K on 2026-02-23 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard multi-item voluntary earnings-related disclosure with no quantitative metrics available for balanced analysis.

23-02-2026

Teradata Corp filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No specific details on the event, transaction, financial metrics, or other quantitative data are disclosed in the provided filing information.

23-02-2026

Inmune Bio, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001213900-26-019321, size: 226 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item informational filing with no quantified financial or operational metrics provided.

23-02-2026

Arcellx, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement's nature, parties, terms, dollar value, or financial impacts. No quantitative metrics, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.

23-02-2026

Phreesia, Inc. filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer position, appointment or resignation status, reasons, or financial impacts are provided. The event is categorized as an Officer Change with no quantitative metrics or performance comparisons disclosed.

23-02-2026

BED BATH & BEYOND, INC. filed an 8-K on February 23, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This represents a standard post-earnings disclosure without detailed performance data.

23-02-2026

Viper Energy, Inc. filed an 8-K on 2026-02-23 disclosing under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, or quantitative data are provided in the filing details. This appears to be an informational earnings-related disclosure without detailed performance indicators.

23-02-2026

Dollar Tree, Inc. filed an 8-K on February 23, 2026 (AccNo: 0000935703-26-000020, Size: 1 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of material information and attached exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

23-02-2026

Forward Air Corp filed an 8-K on February 23, 2026 (AccNo: 0001628280-26-010569), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This appears to be a standard earnings-related disclosure, but no specific revenue, earnings, margins, or other quantitative metrics are mentioned in the provided filing details. No positive, negative, or flat performance indicators are disclosed.

23-02-2026

Boise Cascade Co filed a Form 8-K on February 23, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This constitutes a multi-item voluntary disclosure of financial results with no quantitative details available.

23-02-2026

FibroBiologics, Inc. filed an 8-K on February 23, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, or quantitative results are disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure following a shareholder meeting.

23-02-2026

INFINITY NATURAL RESOURCES, INC. filed an 8-K on 2026-02-23 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). Regulation FD disclosure was also provided (Item 7.01) with financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties involved, synergies, or performance comparisons were explicitly stated.

23-02-2026

Ryerson Holding Corp filed an 8-K on February 23, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing accession number is 0001193125-26-064032 with a size of 12 MB, suggesting attachments such as documents or presentations. No specific financial metrics, transactions, events, or other quantitative details are disclosed in the provided filing metadata.

23-02-2026

BellRing Brands, Inc. filed an 8-K on February 23, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are provided in the filing summary. No financial metrics, performance comparisons, or other material changes are mentioned.

23-02-2026

Apple Hospitality REIT, Inc. filed an 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.

23-02-2026

AeroVironment Inc filed an 8-K on 2026-02-23 disclosing matters under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are provided.

23-02-2026

Primerica, Inc. filed an 8-K on February 23, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, with Item 9.01 providing financial statements and exhibits. No specific details on the nature, scope, or impact of the amendments or changes are disclosed. This is a governance-related informational filing with no quantified financial or operational metrics provided.

23-02-2026

ProAssurance Corp filed a Form 8-K on February 23, 2026 (AccNo: 0001127703-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure for a US-listed company in the financial sector. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the filing details provided.

23-02-2026

Cleveland-Cliffs Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative impacts are disclosed. No positive or negative metrics are mentioned.

23-02-2026

Digital Asset Acquisition Corp. filed an 8-K on February 23, 2026 (AccNo: 0001213900-26-019337) disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits, related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or other quantitative details are disclosed in the provided filing information. Sector is not specified.

23-02-2026

Addus HomeCare Corp filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

23-02-2026

Aethlon Medical Inc. filed an 8-K on February 23, 2026 (AccNo: 0001683168-26-001259), disclosing events under Items 5.02, 5.03, 5.07, and 9.01. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Items 5.03 and 5.07 address amendments to articles of incorporation or bylaws/change in fiscal year and submission of matters to a vote of security holders, respectively; no specific details, metrics, or outcomes are disclosed.

23-02-2026

Generation Income Properties, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-064004), disclosing under Item 2.01 the completion of an acquisition or disposition of assets. No specific details on transaction parties, structure, valuation, or financial impacts are provided in the filing summary. Sector is not specified.

23-02-2026

Functional Brands Inc. filed an 8-K on 2026-02-23 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, transaction values, dollar amounts, percentages, or financial impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

23-02-2026

Offerpad Solutions Inc. filed an 8-K on 2026-02-23 furnishing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard voluntary disclosure of quarterly or annual financial results.

23-02-2026

Sharps Technology Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, transaction values, dollar amounts, names of individuals or counterparties, financial impacts, or quantitative metrics were provided in the filing summary. This represents a multi-item mandatory filing with unknown implications due to lack of disclosed substance.

23-02-2026

Healthcare Realty Trust Inc filed an 8-K on February 23, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits, likely related to the accountant change documentation. No financial metrics, quantitative impacts, reasons for the change, or performance variations (positive, negative, or flat) are mentioned.

23-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 23, 2026 (AccNo: 0001574085-26-000015, size 368 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for voluntary disclosure of material non-public information with attached exhibits. No financial metrics, transactions, positive or negative changes, or other quantitative details are provided in the filing summary.

23-02-2026

Adeia Inc. filed a Form 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics available.

23-02-2026

Claritev Corp filed a Form 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item voluntary earnings-related filing with no specific revenue, earnings, or other quantitative metrics provided in the filing description. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are detailed.

23-02-2026

Compass, Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed. Sector information is not specified.

23-02-2026

Genworth Financial Inc filed an 8-K on 2026-02-23 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing related to financial results with no specific revenue, earnings, guidance, or period-over-period metrics provided in the filing description. No positive or negative financial changes are detailed.

23-02-2026

SI-BONE, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.02 results of operations and financial condition, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. This is a multi-item filing covering significant corporate, financial, and personnel developments. No specific transaction details, financial metrics, personnel names, dollar values, or performance comparisons are disclosed.

23-02-2026

Sixth Street Specialty Lending, Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, or any financial metrics are NOT_DISCLOSED. No quantitative data, performance metrics, or scheduled events are provided in the available information.

23-02-2026

Skyward Specialty Insurance Group, Inc. filed an 8-K on 2026-02-23 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance indicators.

23-02-2026

Paymentus Holdings, Inc. filed an 8-K on 2026-02-23 under Item 2.02 announcing results of operations and financial condition. No specific financial metrics, revenue figures, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. Sector not specified.

23-02-2026

DMC Global Inc. filed an 8-K on February 23, 2026 (AccNo: 0000034067-26-000008, Size: 1 MB), disclosing Results of Operations and Financial Condition under Item 2.02 along with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance changes, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with attached exhibits containing further information.

23-02-2026

Great Lakes Dredge & Dock Corp filed an 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related filing with no detailed performance data available.

23-02-2026

Oric Pharmaceuticals, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-063974), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary disclosure for financial results without quantified metrics available.

23-02-2026

Allison Transmission Holdings Inc filed an 8-K on 2026-02-23 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the filing information provided. This is a standard multi-item earnings-related disclosure with no quantitative metrics available for analysis.

23-02-2026

MediaAlpha, Inc. filed a Form 8-K on 2026-02-23 reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics were disclosed in the provided filing information.

23-02-2026

Angel Studios, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's terms, parties, dollar value, or financial impacts are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or operational effects are mentioned.

23-02-2026

VEEA INC. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No transaction details, dollar values, parties involved, financial impacts, or other metrics are disclosed.

23-02-2026

Ventyx Biosciences, Inc. filed an 8-K on February 23, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or scheduled events are disclosed in the provided filing information. This appears to be a single-item, likely voluntary disclosure with no quantitative data available.

23-02-2026

Houston American Energy Corp filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007761), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, or financial impacts were disclosed. This multi-item filing indicates potential strategic or financing developments but provides no specifics for impact assessment.

• ·File size: 932 KB
• ·Multi-item mandatory 8-K filing

23-02-2026

Diversified Healthcare Trust filed an 8-K on February 23, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. All quantitative metrics and detailed financial impacts are NOT_DISCLOSED.

23-02-2026

Brighthouse Financial, Inc. filed a Form 8-K on 2026-02-23 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are disclosed in the provided filing information.

23-02-2026

SharonAI Holdings, Inc. filed a Form 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information previously disclosed selectively, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents. No specific transaction details, financial metrics, or quantitative data are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative performance metrics.

23-02-2026

Cross Country Healthcare Inc filed an 8-K on February 23, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary release of material nonpublic information with attached exhibits. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary.

23-02-2026

DHI Group, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001393883-26-000045, Size: 227 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

23-02-2026

Invest Green Acquisition Corp announced entry into a Material Definitive Agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 in its 8-K filing dated February 23, 2026. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

Ingevity Corp filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative impacts are disclosed.

23-02-2026

Kadant Inc filed a Form 8-K on February 23, 2026 (AccNo: 0000886346-26-000015), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing related to financial results. No specific revenue, earnings, margins, guidance, or period-over-period metrics are disclosed in the provided information.

23-02-2026

NATIONAL HEALTH INVESTORS INC filed an 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions affected, names, reasons for change, or quantitative metrics are disclosed.

23-02-2026

Pure Storage, Inc. filed a Form 8-K on February 23, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. No specific details regarding the nature of the amendments, effective date, strategic rationale, or any financial impacts are provided in the filing information. This appears to be a single-item informational filing with no quantified metrics or directional implications disclosed.

23-02-2026

ONEOK INC /NEW/ filed a Form 8-K on February 23, 2026 (AccNo: 0001039684-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, balance sheet details, guidance, or performance metrics are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or strategic updates are provided in the filing summary.

23-02-2026

Invesco Ltd. filed a Form 8-K on February 23, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No quantitative data, comparisons, or scheduled events are mentioned.

23-02-2026

UFP Industries Inc filed an 8-K on February 23, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This represents a standard voluntary disclosure of financial results.

23-02-2026

Clearway Energy, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001628280-26-010641), reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results, with no specific revenue, earnings, guidance, or other quantitative metrics disclosed in the provided information. No period-over-period comparisons, transaction details, or scheduled events are mentioned.

23-02-2026

Martin Marietta Materials Inc. filed an 8-K on 2026-02-23 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

Erie Indemnity Co filed an 8-K on February 23, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing likely including earnings exhibits, but details such as guidance or balance sheet impacts are NOT_DISCLOSED.

23-02-2026

OCTAVE SPECIALTY GROUP INC filed an 8-K on February 23, 2026 (AccNo: 0001628280-26-010639, Size: 929 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

23-02-2026

Antero Midstream Corp filed an 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary release of material nonpublic information with attached exhibits. No specific financial metrics, transactions, or performance data are disclosed.

23-02-2026

JPMorgan Chase & Co filed a Form 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure, which typically involves voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, indicating attachments such as press releases or presentations. No specific core event, financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are present.

23-02-2026

Antero Resources Corp filed an 8-K on February 23, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a multi-item voluntary disclosure to comply with Regulation FD requirements.

23-02-2026

TRICO BANCSHARES filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transaction details, or scheduled events mentioned.

23-02-2026

Quaker Chemical Corp filed an 8-K on February 23, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing details provided. This is a standard earnings-related disclosure with no quantified positive or negative performance indicators available.

23-02-2026

HealthStream Inc filed an 8-K on February 23, 2026 (AccNo: 0001437749-26-005117), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing details. No positive or negative performance indicators, period-over-period changes, or strategic updates are mentioned.

23-02-2026

Flowers Foods Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key position affected, individual names, appointment or resignation status, reasons for change, or financial metrics are disclosed. No positive or negative performance metrics, period-over-period comparisons, or quantitative data provided.

23-02-2026

Shutterstock, Inc. filed an 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary.

23-02-2026

STONERIDGE INC filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the key position affected, names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or further context provided in the filing summary.

23-02-2026

Boston Scientific Corp filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any financial metrics are disclosed.

• ·AccNo: 0000885725-26-000013
• ·File size: 254 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

Lunai Bioworks Inc. filed a Form 8-K on 2026-02-23 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, effective dates, or exchange involved were disclosed. This represents a material negative event with no offsetting positive information provided.

• ·AccNo: 0001731122-26-000282
• ·Filing size: 190 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

JBT Marel Corp filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED in the provided filing information. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are explicitly stated.

23-02-2026

BV Financial, Inc. filed an 8-K on February 23, 2026, reporting under Item 4.01 a change in its certifying accountant. Item 9.01 discloses financial statements and exhibits related to this change. No financial metrics, reasons for the change, or other quantitative details are provided.

23-02-2026

Boxlight Corp filed a Form 8-K on February 23, 2026 (AccNo: 0001628280-26-010677), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary. No quantitative data, comparisons, or strategic context is available.

23-02-2026

Reborn Coffee, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No financial metrics, transaction values, or quantitative impacts were disclosed in the provided filing summary. This represents a multi-item filing focused on significant regulatory and leadership events.

23-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-23 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits related to a merger/acquisition event. No quantitative metrics, period-over-period comparisons, deal structure details, parties involved, valuation, synergies, regulatory pathways, or shareholder impacts were explicitly stated in the filing summary. This filing appears informational with all key transaction specifics NOT_DISCLOSED.

23-02-2026

Alpha Cognition Inc. filed an 8-K on February 23, 2026 (AccNo: 0001213900-26-019355), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any board composition impacts are NOT_DISCLOSED. No quantitative financial metrics, scheduled events, or governance implications are mentioned.

• ·Filing size: 190 KB
• ·Sector: not specified

23-02-2026

Myseum, Inc. filed an 8-K on February 23, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are provided. This appears to be an informational filing with no quantified metrics or directional impacts disclosed.

23-02-2026

Village Farms International, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial metrics, positive or negative impacts, or other quantitative data are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Algorhythm Holdings, Inc. filed a multi-item Form 8-K on February 23, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, terms, financial impacts, or quantitative metrics were disclosed. This filing appears informational without detailed positive or negative elements.

23-02-2026

Ecolab Inc. filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, the officer's name, whether it is an appointment or resignation, reasons for the change, and any timing or succession information are NOT_DISCLOSED. No quantitative data, financial metrics, or further governance implications are provided in the filing summary.

23-02-2026

iSpecimen Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative data are provided in the filing summary. This represents a standard SEC-required disclosure with no additional context on implications.

23-02-2026

KRATOS DEFENSE & SECURITY SOLUTIONS, INC. filed an 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

23-02-2026

Seaport Entertainment Group Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001104659-26-018624, Size: 249 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are explicitly stated. This is a multi-item voluntary disclosure with attached exhibits.

• ·Filing date: 2026-02-23
• ·Accession Number: 0001104659-26-018624
• ·File size: 249 KB
• ·Event Type: General Filing
• ·Sector: NOT_DISCLOSED

23-02-2026

International Battery Metals Ltd. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, accompanied by exhibits under Item 9.01. This multi-item mandatory filing highlights significant corporate actions, where the material agreement represents a potentially strategic development while the unregistered equity sales introduce potential shareholder dilution. No specific transaction values, financial impacts, or other quantitative details are provided.

23-02-2026

EQUITY BANCSHARES INC filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No details on the core event, financial impacts, transactions, or metrics are disclosed in the filing summary provided. This appears to be a single-item voluntary disclosure with no quantitative data or strategic implications specified.

23-02-2026

NOVANTA INC filed a Form 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other financial metrics are mentioned in the provided filing details. This is an informational earnings-related disclosure without quantified performance data.

23-02-2026

I-ON Digital Corp. filed a Form 8-K on February 23, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing highlights potentially significant corporate actions but lacks specifics on positive or negative implications.

23-02-2026

Oncology Institute, Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons for the change, and any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or board composition changes are mentioned.

23-02-2026

Primoris Services Corp filed an 8-K on February 23, 2026 (AccNo: 0001361538-26-000007, Size: 940 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.

• ·AccNo: 0001361538-26-000007
• ·Source: us_sec
• ·Event Type: Financial Results

23-02-2026

Atlas Energy Solutions Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001193125-26-064170), reporting under Item 2.02 its results of operations and financial condition, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing related to financial results release. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing information.

23-02-2026

Twin Vee PowerCats, Co. filed a Form 8-K on February 23, 2026 (AccNo: 0001731122-26-000283), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement, events, transaction terms, financial impacts, or metrics. No quantitative data, period-over-period comparisons, positive or negative metrics, or scheduled events are disclosed.

23-02-2026

Westlake Chemical Partners LP filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-064229), under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. No positive or negative metrics, board outcomes, or governance implications are specified.

23-02-2026

Westlake Corp filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

23-02-2026

INNOVATIVE INDUSTRIAL PROPERTIES INC filed a Form 8-K on 2026-02-23 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific quantitative metrics such as revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are provided in the filing description. No positive, negative, or flat performance indicators are disclosed.

23-02-2026

BRC Inc. filed an 8-K on February 23, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details including names, positions, reasons for changes, timing, or compensation amounts are disclosed.

• ·AccNo: 0001891101-26-000014
• ·File Size: 151 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

Enhabit, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, but specific details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, guidance changes, or scheduled events are mentioned.

23-02-2026

HCM IV Acquisition Corp. filed an 8-K on 2026-02-23 (AccNo: 0001213900-26-019378, Size: 413 KB) under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) in connection with a Merger/Acquisition event. No quantitative metrics, deal terms, parties, strategic rationale, or performance comparisons (positive, negative, or flat) are explicitly stated. All key details including valuation, structure, and impacts remain NOT_DISCLOSED.

23-02-2026

Transocean Ltd. filed a Form 8-K on February 23, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific transaction details, financial metrics, or quantitative data disclosed in the available filing information.

23-02-2026

Better Home & Finance Holding Co filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details including transaction value, parties, terms, financial impacts, or strategic context are disclosed.

23-02-2026

Heritage Insurance Holdings, Inc. filed a Form 8-K on 2026-02-23 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantified metrics available.

23-02-2026

LQR House Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001213900-26-019393, size 202 KB) reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial impacts, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, guidance, or scheduled events are disclosed.

23-02-2026

Dime Community Bancshares, Inc. /NY/ filed a Form 8-K on February 23, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events, transactions, or exhibits provided. No quantitative metrics, positive or negative changes, or financial impacts are disclosed.

23-02-2026

BWX Technologies, Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, comparisons, or guidance details are disclosed in the provided filing information. All quantitative data such as transaction values, percentages, or period-over-period changes are NOT_DISCLOSED.

23-02-2026

Innovex International, Inc. filed an 8-K on February 23, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, quantitative data, period-over-period comparisons, or other details such as revenue, earnings, guidance, or balance sheet effects are disclosed in the provided filing information.

23-02-2026

AST SpaceMobile, Inc. filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transaction values, or metrics are disclosed in the provided filing summary. Sector information is not specified.

23-02-2026

Organogenesis Holdings Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, comparisons, or scheduled events are mentioned.

23-02-2026

Cannae Holdings, Inc. filed an 8-K on February 23, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing announcing financial results with attached exhibits.

• ·Accession Number: 0001704720-26-000025
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

23-02-2026

Mueller Water Products, Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

23-02-2026

Silo Pharma, Inc. filed a Form 8-K on February 23, 2026, reporting unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific transaction details, share counts, dollar values, or financial metrics are disclosed. This multi-item filing signals potential capital raising via dilutive equity issuance, but lacks quantification of impact.

23-02-2026

OLB Group, Inc. filed an 8-K on February 23, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no quantitative details on transaction values, financial impacts, or strategic implications disclosed in the provided information. No revenue, earnings, balance sheet effects, or guidance changes are mentioned.

23-02-2026

Willow Lane Acquisition Corp. II filed an 8-K on 2026-02-23 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties involved beyond the filer, valuation, financial terms, or quantitative metrics are disclosed in the filing summary provided. No positive or negative performance metrics are mentioned.

23-02-2026

BARNWELL INDUSTRIES INC filed an 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative data are provided in the filing summary. Sector is not specified.

• ·AccNo: 0001140361-26-006428
• ·Size: 232 KB
• ·Sector: not specified

23-02-2026

Verizon Communications Inc filed an 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing summary provided.

23-02-2026

Keurig Dr Pepper Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001193125-26-064353, Size: 2 MB) reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, financial metrics, dollar values, or period-over-period comparisons provided in the summary. No positive or negative quantitative impacts are disclosed.

• ·Filing Accession Number: 0001193125-26-064353
• ·Filing Size: 2 MB

23-02-2026

ContextLogic Holdings Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0000902664-26-001243, Size: 188 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the financial statements/exhibits are disclosed. This is a multi-item filing with no quantified metrics, positive or negative, provided.

• ·Filing Accession Number: 0000902664-26-001243
• ·Filing Size: 188 KB

23-02-2026

Vir Biotechnology, Inc. filed a multi-item Form 8-K on February 23, 2026, reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, share counts, or period-over-period comparisons are disclosed. The filing indicates potentially significant developments but provides no quantitative data for impact assessment.

23-02-2026

AMC Networks Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics (positive, negative, or flat) are disclosed. This multi-item filing signals a potentially significant development, but lacks quantitative data for assessment.

23-02-2026

23-02-2026

Empire Petroleum Corp filed an 8-K on 2026-02-23 disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 2.03 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No quantitative transaction values, financial impacts, or strategic details are disclosed. This is a multi-item mandatory filing with no specified positive or negative metrics.

23-02-2026

HA Sustainable Infrastructure Capital, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are provided.

23-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, or exhibits are disclosed. No financial metrics, positive or negative changes, or quantitative impacts are mentioned.

23-02-2026

TCW Strategic Income Fund Inc filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 8.01 Other Events. No specific details regarding the nature of the agreement, transaction size, financial impacts, or other quantitative metrics are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Palomar Holdings, Inc. filed an 8-K on February 23, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or performance comparisons are disclosed in the filing summary. The filing size is 10 MB with AccNo 0001193125-26-064398.

23-02-2026

SONIDA SENIOR LIVING, INC. filed an 8-K on February 23, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or compensation amounts are provided.

23-02-2026

Armada Acquisition Corp. III filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. The filing also covers Item 3.02 unregistered sales of equity securities, Item 5.02 changes in directors or officers including compensatory arrangements, Item 5.03 amendments to articles of incorporation or bylaws, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific deal terms, financial metrics, target company, valuation, or quantitative data are disclosed.

23-02-2026

Lottery.com Inc. filed an 8-K on 2026-02-23 (AccNo: 0001493152-26-007783) disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. No financial terms, parties involved, deal valuation, strategic rationale, or other quantitative metrics are mentioned. The filing provides limited details on this completed transaction.

23-02-2026

Verses AI Inc. filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007782), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

23-02-2026

Texas Mineral Resources Corp. filed an 8-K on February 23, 2026, under Item 3.02 disclosing unregistered sales of equity securities and Item 8.01 for other events. No specific details, transaction sizes, financial impacts, or quantitative metrics are provided in the filing information available. This is a multi-item filing with no mentioned positive or negative performance indicators.

23-02-2026

Lument Finance Trust, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.